DeciFace: Decipher the Influence of Ethnic Backgrounds on the Facial Dysmorphic Features of Rare Mendelian Disorders
1 other identifier
observational
100
1 country
1
Brief Summary
There are more than 7000 known genetic disorders, and the number of affected is estimated to be about 6-10% of the population. Around 30 to 40% of genetic disorders have physical changes in the face and skull such as Down's syndrome or Fragile X syndrome. Therefore, the known facial phenotype of many genetic disorders is highly informative to clinical diagnosis. Since a large number of genetic diseases are associated with special facial phenotypes that are difficult to remember, automated facial analysis such as Face2Gene and GestaltMatcher can assist in the identification and diagnosis of facial phenotypes related to various genetic diseases. Although the current advances in whole exome sequencing (whole exome sequencing) or whole genome sequencing (whole genome sequencing) have greatly improved the diagnostic rate of genetic diseases, about half of the patients are still undiagnosed. For patients with special facial phenotypes, the investigators believe that by combining automated facial analysis and whole exome sequencing data, it should be possible to provide a fast and accurate diagnostic model of genetic mutations for genetic diseases. GestaltMatcher Database is a medical imaging database of rare diseases developed by Professor Peter Krawitz of the University of Bonn, Germany. The database's artificial intelligence module will infer a patient's possible diagnosis based on the patient's photo, age, gender, race, and clinical description. The database will be open to medical researchers in related fields to improve the diagnosis of rare diseases. The investigators will use GestaltMatcher to assist in the diagnosis of patients, and compare the accuracy and significant differences in facial deformities between Taiwanese patients and patients from different countries. And use Eye Tracker to analyze how doctors diagnose patients through facial photos, and compare whether there are significant differences between foreign patients and Taiwanese patients in the diagnosis literature of Taiwanese doctors. The project will also analyze how genetic doctors at the University of Bonn in Germany diagnose patients, and compare it with Taiwanese doctors to better understand the differences in the process of doctors diagnosing patients and ethnic backgrounds.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2023
CompletedFirst Posted
Study publicly available on registry
June 22, 2023
CompletedStudy Start
First participant enrolled
July 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
August 20, 2025
August 1, 2025
1.9 years
May 23, 2023
August 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The diagnosis accuracy rate of use GestaltMatcher to analysis participant facial features in rare diseases
GestaltMatcher is a automated facial analysis software, which utilized deep convolutional neural networks trained on patients' photos as an encoder to convert facial photos into feature vectors to form a Clinical Face Phenotype Space (CFPS). And quantified the similarity among patients by the cosine distance of two vectors in CFPS. With this approach, the investigators can support the ultra-rare syndromes that lack images to be trained and push the supported syndromes. Base on on this technology, the investigators use GestaltMatcher to analysis participant facial features and compare those vectors which are similar to patients to find possible syndromes. The investigators will verify more clinical phenotype and genetic data of the participants for verification.
1 month
The significant difference in facial deformities between Taiwan participant and participant from different countries by GestaltMatcher
The investigators will ues those facial feature vectors from GestaltMatcher Database to compare with Taiwan participants in the research platform within the GestaltMatcher Database to find the facial differences between Taiwan and other different countries participants by pairwise matrix. To find out where is the difference between Taiwan and different countries participants, improving the diagnostic perspectives in Taiwanese groups.
3 years
Secondary Outcomes (2)
Criteria for doctors to diagnose participants from facial features assessed by eye trackers
3 years
Diagnosis differences between Taiwan and Bonn University genetics doctors
3 years
Interventions
We will use the camera to take 2 front and side images of the participant, and select one of the better images to upload to the facial analysis system (GestaltMatcher Database) for analysis.
Eligibility Criteria
Cases with abnormal appearance of clinical symptoms and suspected genetic diseases at National Taiwan University Hospital
You may qualify if:
- Cases with abnormal appearance of clinical symptoms and suspected genetic diseases
You may not qualify if:
- Unable to cooperate with the examiner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Taiwan University Hospitallead
- University of Bonncollaborator
Study Sites (1)
National Taiwan University Hospital
Taipei, 10041, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ni-Chung Lee, M.D., Ph.D.
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2023
First Posted
June 22, 2023
Study Start
July 30, 2024
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
August 20, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share